el propranolol revoluciona el tratamiento de los hemangiomas en la infancia
Clicks: 250
ID: 137819
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
250 views
37 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #31 of 98 articles by views in Endocrine
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Se comunica brevemente acerca del uso del propranolol como opción terapéutica para curar o paliar los hemangiomas en niños. Aunque el mecanismo por el cual actúa el fármaco en estos tumores benignos no es bien conocido, se piensa que pueda estar relacionado con el control de la hipoxia celular, la inducción de apoptosis de las células endoteliales y la inhibición del factor de crecimiento endotelial y fibroblástico.
| Reference Key |
sevilla2013medisanel
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Enrique Berdión Sevilla;Valia Hernández Viel |
| Journal | Endocrine |
| Year | 2013 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.